Journal article
RIG-I Signaling Is Critical for Efficient Polyfunctional T Cell Responses during Influenza Virus Infection
PLoS pathogens, Vol.12(7), pp.e1005754-e1005754
07/2016
DOI: 10.1371/journal.ppat.1005754
PMCID: PMC4954706
PMID: 27438481
Abstract
Retinoic acid inducible gene-I (RIG-I) is an innate RNA sensor that recognizes the influenza A virus (IAV) RNA genome and activates antiviral host responses. Here, we demonstrate that RIG-I signaling plays a crucial role in restricting IAV tropism and regulating host immune responses. Mice deficient in the RIG-I-MAVS pathway show defects in migratory dendritic cell (DC) activation, viral antigen presentation, and priming of CD8+ and CD4+ T cell responses during IAV infection. These defects result in decreased frequency of polyfunctional effector T cells and lowered protection against heterologous IAV challenge. In addition, our data show that RIG-I activation is essential for protecting epithelial cells and hematopoietic cells from IAV infection. These diverse effects of RIG-I signaling are likely imparted by the actions of type I interferon (IFN), as addition of exogenous type I IFN is sufficient to overcome the defects in antigen presentation by RIG-I deficient BMDC. Moreover, the in vivo T cell defects in RIG-I deficient mice can be overcome by the activation of MDA5 -MAVS via poly I:C treatment. Taken together, these findings demonstrate that RIG-I signaling through MAVS is critical for determining the quality of polyfunctional T cell responses against IAV and for providing protection against subsequent infection from heterologous or novel pandemic IAV strains.
Details
- Title: Subtitle
- RIG-I Signaling Is Critical for Efficient Polyfunctional T Cell Responses during Influenza Virus Infection
- Creators
- Matheswaran Kandasamy - Department of Microbiology, The University of Chicago, Chicago, Illinois, United States of AmericaAmol Suryawanshi - Cancer Immunology, Inflammation, and Tolerance Program, GRU Cancer Center, Georgia Regents University, Augusta, Georgia, United States of AmericaSmanla Tundup - Department of Microbiology, The University of Chicago, Chicago, Illinois, United States of AmericaJasmine T Perez - Department of Microbiology, The University of Chicago, Chicago, Illinois, United States of AmericaMirco Schmolke - Department of Microbiology and Molecular Medicine, University of Geneva Medical Faculty, CMU, Geneva, SwitzerlandSanthakumar Manicassamy - Cancer Immunology, Inflammation, and Tolerance Program, GRU Cancer Center, Georgia Regents University, Augusta, Georgia, United States of AmericaBalaji Manicassamy - Department of Microbiology, The University of Chicago, Chicago, Illinois, United States of America
- Resource Type
- Journal article
- Publication Details
- PLoS pathogens, Vol.12(7), pp.e1005754-e1005754
- DOI
- 10.1371/journal.ppat.1005754
- PMID
- 27438481
- PMCID
- PMC4954706
- NLM abbreviation
- PLoS Pathog
- ISSN
- 1553-7366
- eISSN
- 1553-7374
- Publisher
- Public Library of Science
- Grant note
- R01 DK097271 / NIDDK NIH HHS
- Language
- English
- Date published
- 07/2016
- Academic Unit
- Microbiology and Immunology
- Record Identifier
- 9984083278302771
Metrics
34 Record Views